Please Wait...

Lost to Follow-Up

Patients lost to follow-up represent the number one cause of clinical trial delays. Bioclinica's lost to follow-up service, Bioclinica L2FU, optimizes clinical trial success by greatly reducing the number of patients lost to follow-up and, with them, their important data. We locate lost to follow-up clinical trial patients, with the support of a specialized team and a secure online portal that facilitates the encrypted exchange of patient information.

Dedicated to reconnecting patients

7
locating patients lost to follow-up
60
searches successfully implemented
1500
patients found

You don’t want to lose patients to follow-up. Neither do we…

The Bioclinica L2FU service includes:
  • Tiered search approach with various search tactics
  • L2FU portal with full 21 CFR Part 11 compliance
  • Information exchange in a secure online environment in real time for each search
  • Site engagement through updated patient contact information and vital status
  • Protocols to maintain contact with the FDA to implement regulatory guidance

 

Bioclinica addresses the critical need of finding and retaining patients:
  • Unique global presence, with global privacy regulation expertise
  • Engagement with patients, based on 25 years of recruiting, retaining and reentering patients worldwide
  • Ability to leverage data and analytics, with access to proprietary and licensed databases of millions of public records

 

Leverage the Bioclinica L2FU Service

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

Bioclinica is a global company specialized in utilizing data, technology and patient insights to enable more efficient trial conduct. We have the experience of successfully navigating the increasingly globalized clinical research sector where legal, regulatory, language, cultural and other factors present additional challenges.

While many patient-tracking services are private investigation firms that offer patient tracking as one of their services, Bioclinica L2FU focuses solely on finding patients who become lost to follow-up. Through personal contact and the facilitation of long-term patient data capture, Bioclinica L2FU can increase the effectiveness of patient retention efforts via continued patient/caregiver engagement through the reliable delivery of phone calls, text reminders, retention materials, reminders, newsletters and other interventions to study subjects. We know clinical research and patients, and we fully understand the patient process, giving us the Bioclinica advantage.

The Bioclinica Advantage

90
success rate in all countries searched
10
global average – 48 hour US average time to locate missing subjects in North America
55
countries in which we’ve successfully located patients lost to follow-up

Secure access and exchange of information ensures data privacy

The proprietary L2FU portal is a fully validated 21 CFR Part 11 compliant tool utilized to facilitate encrypted patient data exchange between the Bioclinica L2FU team, study sites and sponsors in a secure online environment.

Key portal features include:
  • Full audit trail
  • Conditional access
  • Real-time review of blinded data via reports
  • Site-based data entry of last known information
  • Retrieval of updated PII and vital status

The proprietary L2FU™ portal

Why choose Bioclinica L2FU?

Why choose Bioclinica L2FU™

  •   Achieve your long-term goal of patient retention

  •   Minimize the issue of patients lost to follow-up

  •   Help maintain clinical trial integrity, by reducing missing data

  •   Maintain study timelines by reducing delays due to patient data gaps

  •   Enhance regulatory compliance and post-study surveillance

  •   Greatly reduce clinical trial costs

  •   Provide vital status on subjects

  •   Maximize clinical trial success

CONTACT US

ADDITIONAL RESOURCES

Site Network

Download Brochure

Lost To Follow-Up

Download Brochure

CHANGING REGULATORY ENVIRONMENT IN CHINA: WHAT DOES IT MEAN FOR CLINICAL TRIALS?

DOWNLOAD WHITE PAPER

WHY CHOOSE A SITE NETWORK FOR YOUR CLINICAL TRIALS?

DOWNLOAD WHITE PAPER

FINDING PATIENTS LOST TO FOLLOW-UP

DOWNLOAD WHITE PAPER

Latin America: An Untapped Clinical Trials Resource

Download White Paper

5 WAYS TO IMPROVE ALZHEIMER'S CLINICAL TRIALS

Download Playbook

LOST TO FOLLOW-UP INFOGRAPHIC

DOWNLOAD INFOGRAPHIC

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Thanks everyone who joined us in today's webinar! https://t.co/Wp6D0oLfc3
Bioclinica (1 hour ago)
Kicking off at 11 EST!! https://t.co/v4hMLK9oAZ
Bioclinica (3 hours ago)
BREAKING: Bioclinica Launches NAFLD/NASH Clinical Trials Practice. Helps sponsors apply medical imaging in trials t… https://t.co/JLTxoevbXU
Bioclinica (6 hours ago)
BREAKING: Bioclinica launches #NAFLD #NASH clinical trials practice, helping sponsors apply medical imaging in tria… https://t.co/eUy34LiSAd
Bioclinica (8 hours ago)
Attending the #NASH Summit next week? If so, drop by @bioclinica's exhibit to learn how medical imaging is being u… https://t.co/TNkl7ce4Sq
Bioclinica (Yesterday)
RT @bioclinica: Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the use of n…
Bioclinica (Yesterday)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box